INTRAUTERINE GROWTH RESTRICTION IN PREGNANCY-INDUCED HYPERTENSION: INCIDENCE AND ASSOCIATED FACTORS IN A TERTIARY CARE SETTING OF KHYBER PAKHTUNKHWA, PAKISTAN

Incidence and associated factors of IUGR in pregnancy-induced hypertension women.

Authors

  • Uzma Bibi King Abdullah Teaching Hospital Mansehra, Health Department KPK Author
  • Mehreen Jadoon King Abdullah Teaching Hospital Mansehra, Health Department KPK Author
  • Seema Rafiq King Abdullah Teaching Hospital Mansehra, Health Department KPK Author
  • Zarkash Asmatullah King Abdullah Teaching Hospital Mansehra, Health Department KPK Author

DOI:

https://doi.org/10.2311/dy816s31

Keywords:

Pregnancy-induced hypertension, Intrauterine growth restriction, gestational age, parity, weight

Abstract

Introduction: Pregnancy-induced hypertension (PIH) is one of the leading risk factors, commencing greater fetal and maternal morbidity and mortality worldwide. Among other complications, intrauterine growth restriction (IUGR) is a significant outcome of PIH. In the Pakistani context, the incidence of IUGR in PIH women and comparison with human factors is rarely determined. This study aimed to find the frequencies of IUGR among PIH women presenting to a tertiary care setup and determine the possible effect of age, gestation age, parity, and weight on IUGR. Methods: This cross-sectional study was conducted from 1st March 2023 to 30th August 2023 at the Obstetrics and Gynecology Department of the Ayub Teaching Hospital in Abbottabad. The research comprised 159 pregnant women who had hypertension problems. The researcher underlined that all women underwent ultrasound biometry to determine intrauterine growth limitation per the RCOG criteria. Results: Among the total 159 PIH women with a mean age of 27.691±2.63 years, the incidence of IUGR is 10.7%. IUGR was more prevalent in the 31-40 age group, i.e., 13%, having gestational age more than 30 weeks 16%, 0-2 parity 9.8%, and weight more than 70kg 45.7%. Conclusion: In the Pakistani context, the incidence of IUGR among women with PIH is low compared to neighboring developing countries and requires individualized perinatal care, particularly among older aged, overweight, nulliparous, and beyond 30 weeks of gestation on a priority basis.

 

Downloads

Download data is not yet available.

Author Biographies

  • Uzma Bibi, King Abdullah Teaching Hospital Mansehra, Health Department KPK

    MBBS, FCPS, Medical Officer, Department of Gynecology and Obstetrics

  • Mehreen Jadoon, King Abdullah Teaching Hospital Mansehra, Health Department KPK

    MBBS, FCPS, Medical Officer, Department of Gynecology and Obstetrics

  • Seema Rafiq, King Abdullah Teaching Hospital Mansehra, Health Department KPK

    MBBS, FCPC, Medical Officer, Department of Gynecology and Obstetrics

  • Zarkash Asmatullah, King Abdullah Teaching Hospital Mansehra, Health Department KPK

    MBBS, FCPS, Medical Officer, Department of Gynecology and Obstetrics

References

Richard K. Luger; Benjamin P. Kight. Hypertension In Pregnancy. Stat Pearls. 2022

Agarwal GS, Agrawal AK, Singhal D, Bawiskar D, Shedge SS. Pregnancy-Induced Hypertension Pathophysiology and Contemporary Management Strategies: A Narrative Review. Cureus. 2024 Jul 6;16(7):e63961. doi: 10.7759/cureus.63961. PMID: 39105037; PMCID: PMC11299475.

Dapkekar P, Bhalerao A, Kawathalkar A, Vijay N. Risk Factors Associated With Intrauterine Growth Restriction: A Case-Control Study. Cureus. 2023 Jun 9;15(6):e40178. doi: 10.7759/cureus.40178. PMID: 37431363; PMCID: PMC10329857.

Dinu M, Stancioi-Cismaru AF, Gheonea M, Luciu ED, Aron RM, Pana RC, Marinas CM, Degeratu S, Sorop-Florea M, Carp-Veliscu A, Hodorog AD, Tudorache S. Intrauterine Growth Restriction-Prediction and Peripartum Data on Hospital Care. Medicina (Kaunas). 2023 Apr 16;59(4):773. doi: 10.3390/medicina59040773. PMID: 37109731; PMCID: PMC10145525.

Gordijn S.J., Beune I.M., Thilaganathan B., Papageorghiou A., Baschat A.A., Baker P.N., Silver R.M., Wynia K., Ganzevoort W. Consensus definition of fetal growth restriction: A Delphi procedure. Ultrasound Obstet. Gynecol. 2016;48:333–339. doi: 10.1002/uog.15884. [DOI] [PubMed] [Google Scholar]

Calek E, Binder J, Palmrich P, Eibensteiner F, Thajer A, Kainz T, Harreiter K, Berger A, Binder C. Effects of Intrauterine Growth Restriction (IUGR) on Growth and Body Composition Compared to Constitutionally Small Infants. Nutrients. 2023 Sep 26;15(19):4158. doi: 10.3390/nu15194158. PMID: 37836441; PMCID: PMC10574227.

Jabeen SS, Raoof M, Mumtaz F, Khan B, Shaheen Z. Intrauterine Growth Restriction Among Pregnant Hypertensive Women of Urban and Rural Areas. Pak J Med Dent. 2023;12(3): 29-35. Doi: 10.36283/PJMD12-3/006

Barros FC, Barros AJ, Villar J, Matijasevich A, Domingues MR, Victora CG. How many low birthweight babies in low-and middle-income countries are pre-term? Revista de Saúde Pública. 2011;45(3):607-16. [DOI:10.1590/S0034-89102011005000019] [PMID]

A E-BM, TS E-D, AM E-N. Environmental factors and apoptotic indices in patients with intrauterine growth retardation: a nested case-control study. Environ Toxicol Pharmacol. 2015 39(2):589-96. [DOI:10.1016/j.etap.2015.01.009] [PMID]

Zafar H, Naz M, Fatima U, Irshad F. Frequency of IUGR in pregnancy induced hypertension. J Uni Med Dent Coll. 2012;3(2):8-13.

Fox NS, Saltzman DH, Oppal S. The relationship between pre-eclampsia and intrauterine growth restriction in twin pregnancies. Am J Obstet Gynecol. 2014;211:x-ex-x-ex.

Almuhaytib FA, AlKishi NA, Alyousif ZM. Early Onset Pre-eclampsia and Intrauterine Growth Restriction: A Case Report. Cureus. 2023 Jan 18;15(1):e33919. doi: 10.7759/cureus.33919. PMID: 36819307; PMCID: PMC9936916.

Gudeta TA, Regassa TM. Pregnancy Induced Hypertension and Associated Factors among Women Attending Delivery Service at Mizan-Tepi University Teaching Hospital, Tepi General Hospital and Gebretsadik Shawo Hospital, Southwest, Ethiopia. Ethiop J Health Sci. 2019 Jan;29(1):831-840. doi: 10.4314/ejhs.v29i1.4. PMID: 30700950; PMCID: PMC6341446.

Majeed S, Khawaja A, Tunio NA, Unar F, Khan FA. To Determine Frequency of Intrauterine Growth Restriction in Pregnancy Induced Hypertension. PJMHS 2020;14(2):240-42

Febrina NAD, Primadi A, Lestari W. Association between Intrauterine Growth Restriction and Pregnancy Hypertension. AMJ.2016;3(2):212-5

Dumolt JH, Powell TL, Jansson T. Placental Function and the Development of Fetal Overgrowth and Fetal Growth Restriction. Obstet Gynecol Clin North Am. 2021 Jun;48(2):247-266. doi: 10.1016/j.ogc.2021.02.001. PMID: 33972064; PMCID: PMC8117119.

Napso T, Lean SC, Lu M, Mort EJ, Desforges M, Moghimi A, Bartels B, El-Bacha T, Fowden AL, Camm EJ, Sferruzzi-Perri AN. Diet-induced maternal obesity impacts feto-placental growth and induces sex-specific alterations in placental morphology, mitochondrial bioenergetics, dynamics, lipid metabolism and oxidative stress in mice. Acta Physiol (Oxf). 2022 Apr;234(4):e13795. doi: 10.1111/apha.13795. Epub 2022 15th February. PMID: 35114078; PMCID: PMC9286839.

Qamar MK, Khan YQ, Irum N, Manzppr S. Frequency of Intrauterine Growth Retardation in Obese Pregnant Females: A Cross Sectional Study in Two Tertiary Care Hospitals of Pakistan. J Soc Obstet Gynaecol Pak. 2021; 11(4):246-249.

Published

04/27/2025

Issue

Vol. 1 No. 1 (2025): The Genesis of MedPulse: Pioneering Research and Clinical Excellence

Section

Original Articles

License

Copyright (c) 2025 MedPulse Spectrum

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

  1. Grant of License: By submitting content (including but not limited to articles, manuscripts, and multimedia) to MedPulse Spectrum Journal, you grant us a non-exclusive, worldwide, royalty-free license to reproduce, distribute, publicly display, and perform the submitted content for the purpose of publishing, promoting, and improving the Journal.

  2. Copyright Ownership: Authors retain the copyright to their work published in MedPulse Spectrum Journal. We request, however, an exclusive license to be the first to publish the work, after which the authors are free to republish, reproduce, or distribute their content with proper acknowledgment of its initial publication in MedPulse Spectrum Journal.

  3. Attribution: Authors agree that their submitted content will be appropriately attributed to them in connection with its use by MedPulse Spectrum Journal.

  4. Permissions: Authors are responsible for obtaining any necessary permissions for the use of third-party materials included in their submissions and must provide evidence of such permissions upon request.

  5. Modification and Removal: MedPulse Spectrum Journal reserves the right to make necessary editorial modifications to submitted content for clarity, consistency, and adherence to journal standards. Authors can request content removal, subject to the Journal's discretion, recognizing that previous versions may persist in the Journal's archives.

  6. Non-Commercial Use: The use of content from MedPulse Spectrum Journal is intended for non-commercial purposes. Any commercial use requires explicit written permission from the Journal.

By submitting content to MedPulse Spectrum Journal, you acknowledge and agree to these licensing terms. The Journal reserves the right to update these terms periodically.

How to Cite

INTRAUTERINE GROWTH RESTRICTION IN PREGNANCY-INDUCED HYPERTENSION: INCIDENCE AND ASSOCIATED FACTORS IN A TERTIARY CARE SETTING OF KHYBER PAKHTUNKHWA, PAKISTAN: Incidence and associated factors of IUGR in pregnancy-induced hypertension women. (2025). MedPulse Spectrum, 1(1). https://doi.org/10.2311/dy816s31